![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 16, 13812-13820, April 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Arthritis and Immune Disorder Research Centre, University
Health Network and the Department of Immunology, University of Toronto,
Toronto, Ontario M5G 2M9, Canada
Received for publication, December 19, 2001, and in revised form, January 3, 2002
Depletion of Ca2+ from the
endoplasmic reticulum (ER) induces large increases in cytoplasmic
Ca2+, mitochondrial Ca2+ loading, protein
synthesis inhibition, and cell death. To clarify the connections among
these events, we have evaluated the effect of Ca2+
mobilizing agents thapsigargin (Tg), econazole (Ec), and the growth
factor Steel Factor (SLF) on bone marrow-derived mast cells (BMMCs).
BMMC Ca2+ stores were found to consist of a Tg-sensitive ER
compartment, the Tg-insensitive SIC store, and mitochondrial stores.
Low levels of Ec interfered with Tg-stimulated mitochondrial loading
while promoting progressive leakage of Ca2+ from the ER.
Low levels of Ec completely reversed Tg toxicity while higher levels
blocked store-operated influx and induced cell death in a SLF-enhanced
manner. Both Ec and Tg inhibited protein synthesis, however, only SLF
plus Tg or very high levels of Ec were able to significantly stimulate
EIF-2 In non-excitable cells, ligand-receptor interactions that activate
phospholipase C stimulate increases in cytoplasmic
Ca2+
([Ca2+]c)1
through the release of Ca2+ from the endoplasmic reticulum
(ER) (1). ER Ca2+ release stimulates the opening of
store-operated Ca2+ channels (SOCs) in the plasma membrane
(2), leading to sustained increases in [Ca2+]c
which can last for several minutes after the initiating signal. In
parallel, Ca2+-ATPases located on the ER (SERCA) and plasma
membrane actively remove Ca2+ from the cytosol, promoting
the return of [Ca2+]c to resting levels. In
addition, mitochondrial uptake of Ca2+ can decrease peak
[Ca2+]c. As Ca2+-ATPase-induced
efflux of Ca2+ decreases [Ca2+]c,
mitochondrial Ca2+ is released, thereby extending the total
time of the Ca2+ transient (3, 4). As such,
Ca2+ signals are regulated through the coordinated activity
of elements in the plasma membrane, ER, and mitochondria.
The ER consists of physiologically distinct Ca2+ stores
that have been classified by their sensitivity to pharmacological
inhibition. The inositol 1,4,5-trisphosphate-sensitive ER compartment
can be emptied by exposure to thapsigargin (Tg), which is an
irreversible SERCA inhibitor (5). Inositol
1,4,5-trisphosphate-insensitive compartments of the ER can be further
distinguished into ryanodine (ryanodine)/caffeine-sensitive stores and
ryanodine/caffeine-insensitive Ca2+ stores (SIC store)
(6).
Tg is toxic to a variety of cell types and its mechanism of toxicity
has been the subject of considerable investigation. One model proposes
that the large increase in [Ca2+]c stimulated by
Tg is primarily responsible for its toxicity (7). Increased cytosolic
Ca2+ content leading to concomitant increases in
mitochondrial [Ca2+] can stimulate the mitochondrial
permeability transition, initiation of the caspase cascade, and
apoptosis (7). An alternate model proposes that depletion of ER
Ca2+ content is a major contributing factor in Tg toxicity.
Ca2+-dependent ER-resident chaperones are
required to promote protein folding. ER Ca2+ depletion
therefore produces unfolded proteins, which tend to self-aggregate,
leading to the immobilization of the ER-Golgi transport system (8). It
has been documented that Tg-mediated ER Ca2+ depletion can
suppress protein synthesis as part of the unfolded protein response.
This response is effected through the kinases PKR and PERK which
phosphorylate translation initiation factor EIF2 Since many biological agonists stimulate Ca2+ release from
the ER, such signals may also modulate ER stress due to
Ca2+ depletion. To clarify the connection between ER
Ca2+ depletion, protein synthesis, and cell viability, we
have evaluated the effect of Ca2+ mobilizing agent Tg, SOC
antagonist Ec, and the growth factor Steel Factor (SLF) on bone
marrow-derived mast cells (BMMCs). Econazole, like Tg, depletes ER
Ca2+ (15), but unlike Tg also blocks SOC-mediated
Ca2+ influx (16). The ability to decouple ER depletion from
influx therefore makes Ec a useful pharmacological tool. BMMCs are
ex vivo non-adhering mast cells morphologically similar to
mucosal mast cells. Ca2+ signals play important roles in a
variety of mast cell functions including degranulation (17, 18),
cytokine synthesis (1, 19, 20), cell survival and proliferation (21,
22). SLF, the ligand for the c-Kit receptor tyrosine kinase, is one of
the primary regulators of mast cell survival, growth, and
differentiation (23). As with many growth factors and their receptors,
one of the key signal transduction events resulting from the binding of
SLF to c-Kit is activation of phospholipase C- Cell Culture--
BMMCs were generated from C57/Bl6 mice
as previously described (25). Cells were cultured in Opti-MEM
(Invitrogen, Grand Island, NY) supplemented with 5% heat-inactivated
fetal bovine serum and 4% WEHI-3 supernatant (source of IL-3) for 5 to
10 weeks prior to use in these experiments. All cultures contained 55 µmol/liters Clonogenicity Assays--
The clonogenicity of treated cells was
determined by measuring colony forming ability in semi-solid medium.
BMMCs (5 × 104) were incubated in 100 µl of
ITS-RPMI in 96-well plates in the presence of treatments for the
indicated time periods. At the end of the culture period, BMMCs
(104 cells) were transferred into RPMI containing fetal
bovine serum (10%), IL-3 (4% WEHI-3 supernatant), SLF (1 µg/ml;
produced as previously described (21)), IL-4 (1.5 ng/ml; R&D Systems,
MI), and 0.9% methylcellulose (4000 centipoises; Stem Cell
Technologies, Vancouver) for 8 to 10 days. At the end of the incubation
period, the number of colony forming units was determined.
Specrofluorimetry--
[Ca2+]c
measurements were performed by flow cytometry. BMMCs (5 × 105 cells/ml) were growth factor-deprived for ~2 h in
Tyrode's buffer (HEPES (10 mM), NaCl (100 mM),
KCl (5 mM), CaCl2 (1.4 mM),
MgCl2 (1 mM), glucose (5.6 mM), and
BSA (0.05%)). Subsequently, cells were incubated in loading buffer (30 min; 5 µM indo-1AM, 0.03% pluronic F-127 in Tyrode's
buffer), washed (2 times), and incubated (greater than 15 min; 4 °C)
to allow for the complete removal and/or conversion of indo-1AM to
Ca2+-sensitive indo-1. Measurements were performed using a
laser tuned to 338 nm while monitoring emissions at 405 and 450 nm. The
concentration of intracellular free Ca2+ was calculated
according to the following formula (26).
Detection of the SIC Store--
To quantify the Ca2+
content of the SIC store, indo-1-loaded BMMCs were treated with FCCP
and Tg to deplete the Ca2+ content of the mitochondria and
ER, respectively, in the presence of Ni2+, an inhibitor of
transmembrane Ca2+ influx (EGTA caused excessive
nonspecific loss of Ca2+ in BMMCs over extended incubation;
data not shown). The Ca2+ ionophore ionomycin was then
added in the presence of EGTA, which will release all of the remaining
Ca2+ from the cell. Based upon the findings of Pizzo
et al. (6), this Ca2+ comes from the SIC store.
The magnitude of the ionomycin-induced Ca2+ transient was
compared qualitatively between BMMCs under different conditions.
EIF-2
After transfer, the nitrocellulose membranes were blocked (1 h, room
temperature in Tris-buffered saline-Tween 20 (TBST; Tris (10 mM), NaCl (150 mM), Tween 20 (0.1%), pH 8.0))
containing powdered skim milk (2%; Carnation) and subsequently
incubated (overnight, 4 °C) with rabbit anti-mouse EIF-2 Protein Synthesis Measurement--
Cells (5 × 105/sample) were collected, washed with phosphate-buffered
saline, and then re-suspended in ITS-RPMI (RPMI supplemented with
insulin (10 µg/ml)-transferrin (5.5 µg/ml)-selenite (5 ng/ml; Sigma) and fatty acid-free BSA (0.05%; Sigma)). Cells were treated with Ec (0, 4, 8, and 12 µM) and/or Tg (30 nM) for 15 min or 5.5 h. After centrifugation (2500 rpm; 5 min), cells were pulse-labeled with [3H]leucine
(50 µCi/ml) for 10 min (37 °C; 5% CO2) in
leucine-free ITS-RPMI. After two washes in RPMI, pellets were lysed
with Triton (50 µl; 0.5% in phosphate-buffered saline) followed by
trichloroacetic acid (50 µl, 10% w/v; 4 °C). Samples were washed
in trichloroacetic acid (5% w/v), and the protein pellets were
re-suspended in microscintillant (Packard, Meriden, CT) and measured
using a microplate scintillation counter (Packard).
Statistical Analysis--
Colony data was analyzed by two-way
analysis of variance, with differences between individual means
determined by Bonferroni's post-tests. Data were expressed as
mean ± S.E.
Ca2+ Stores in
BMMCs--
[Ca2+]c was monitored in
indo-1-loaded BMMCs by flow cytometry. We found that basal
[Ca2+]c in BMMCs was 93 ± 5.8 nM (n = 25). Preliminary studies were
performed to assess the identity of ER Ca2+ stores in
BMMCs. Exposure to ryanodine did not result in significant increases in
[Ca2+]c (Fig.
1A), suggesting that no
ryanodine-sensitive Ca2+ stores are present in this cell
type. In contrast, exposure of BMMCs to Tg resulted in a large increase
in [Ca2+]c even in the absence of extracellular
Ca2+ (Fig. 1B), consistent with the presence of
Tg-sensitive Ca2+ stores. The SIC store is not fully
characterized but can be detected by treating cells with
Ca2+ ionophore after other stores (i.e.
mitochondria and Tg-sensitive stores) have been depleted. We therefore
pretreated cells with FCCP and Tg to release Ca2+ from
mitochondria and Tg-sensitive stores, respectively, and also incubated
cells in Ni2+ to block influx. As shown in Fig.
1B, exposure of these cells to ionomycin/EGTA reveals a pool
of Ca2+ indicating the existence of the SIC store (Fig.
1B). Consequently, BMMCs contain three intracellular
Ca2+ stores, the mitochondria and two functionally
distinguishable ER compartments based upon Tg sensitivity.
Econazole-induced Mobilization of Intracellular
Ca2+--
To determine the direct effects of Ec on
Ca2+ stores in BMMCs, a preliminary dose response was
performed to determine the effective concentration. In the presence of
0.05% BSA, we observed instantaneous Ec-induced increases in
[Ca2+]c at concentrations above 30 µM. Based upon the findings of Gamberucci et
al. (27) and our own observations, the presence of BSA decreases
free Ec concentrations, thereby accounting for the difference in dose
requirement compared with previous studies in Madin-Darby canine kidney
cells (15). Under the conditions of the current study, 115 ± 8.4 nM (n = 8) increases in
[Ca2+]c which maintained themselves for several
minutes after the addition of Ec were observed (Fig.
2A). Moreover, the subsequent addition of Tg (2 µM) failed to stimulate further
increases in [Ca2+]c (n = 3),
suggesting that Ec induces the release of Ca2+ from
Tg-sensitive stores. To determine whether the SIC store is similarly
emptied by Ec, residual Ca2+ content following exposure to
FCCP and Ec (30 µM) was measured using ionomycin/EGTA. As
shown in Fig. 2B, the SIC store was not emptied following Ec
exposure (n = 3), suggesting that Tg-sensitive stores
are the primary Ec targets.
SLF-enhanced, Econazole-induced Blockage of SOC and Depletion of
Tg-sensitive Ca2+ Stores--
Although no instantaneous
Ec-induced changes in [Ca2+]c were observed at
concentrations less than 30 µM, the imidazole has potent
effects on BMMC viability at much lower concentrations. However, this
may be the result of cumulative effects over longer incubation. To
assess this possibility, cells were incubated for 3 h with Ec (0, 4, 8, 12, and 15 µM) in the presence of SLF, a Ca2+-mobilizing growth factor or IL-3, a growth-promoting
cytokine that does not mobilize Ca2+. Tg was used to
release ER Ca2+. We observed that Tg-induced changes in
[Ca2+]c were increased in SLF-stimulated cells
(Fig. 3A) in comparison with
IL-3-stimulated cells (Fig. 3B). However, this difference
was lost in the presence of Ec at concentrations greater than 8 µM. Second, the peak Tg-induced
[Ca2+]c increased as Ec concentrations increased
up to 8 µM, after which point Tg-induced
[Ca2+]c began to decrease, with highly
significant attenuation of Tg-induced Ca2+ release observed
at 15 µM Ec (Fig. 3C). Finally, while
Tg-induced changes in [Ca2+]c normally stabilize
at a [Ca2+]c well above normal, Ec dose
dependently decreased steady state Tg-induced
[Ca2+]c between 8 and 15 µM, at
which point Tg-induced [Ca2+]c returned to basal
levels indicating inhibition of SOC-mediated influx. Two-way ANOVA
analysis of the data in Fig. 3C revealed that the
differences observed between SLF and IL-3 were significant
(p < 0.05), as was the variation due to Ec
(p < 0.0001).
In the presence of Ni2+, Tg-induced increases in
[Ca2+]c come only from internal Ca2+
stores. Consequently, comparison of the amount of Tg-releasable Ca2+ can be used to estimate the relative amount of
Ca2+ in the Tg-sensitive Ca2+ store. In this
case, an acceleration in the rate of [Ca2+]c
increase in the presence of SLF was noted although no overall
difference in total Tg releasable Ca2+ was observed between
SLF (Fig. 3D) and IL-3 (Fig. 3E). A linear dose-dependent decrease in ER Ca2+ content was
observed for Ec between 4 and 15 µM (Fig. 3F).
Therefore, Ec induces dose-dependent decreases in ER
Ca2+ content which led to enhanced Ca2+ release
after the addition of Tg and was enhanced by the presence of SLF.
Finally, at the highest doses studied (between 12 and 15 µM) Ec-induced inhibition of Ca2+ influx was observed.
Ec Suppresses Mitochondrial Ca2+ Uptake--
BMMCs
treated with 2 µM Tg typically displayed a two-step
increase in [Ca2+]c (see Fig. 3, A and
B, insets). The first step is characterized by a slow,
~2-fold increase in [Ca2+]c, and is followed by
a more rapid and extensive second step with
[Ca2+]c peaking between 600 and 1,000 nM. We observed that Ec concentrations as low as 4 µM eliminated the first step of the Tg-induced
Ca2+ transient. We also observed that FCCP, the
protonophore that collapses the mitochondrial membrane potential
preventing Ca2+ entry into the mitochondria, also
eliminated the first step of the Tg-induced Ca2+ rise (not
shown). These observations therefore suggested that the slower nature
of the first step of the Ca2+ rise was due to mitochondrial
buffering, and that Ec could interfere with this process. To test this
possibility, we pretreated cells with Ec, exposed them to Tg, and then
probed mitochondrial Ca2+ content by adding FCCP, which
releases mitochondrial Ca2+ into the cytoplasm. As shown in
Fig. 4, in the absence of Ec, Tg
pretreatment followed by FCCP results in a large increase in [Ca2+]c. In contrast, cells pretreated with Ec
failed to release any Ca2+ into the cytoplasm following
FCCP treatment. These results therefore suggest that Ec pretreatment
interferes with the ability of mitochondria to load Ca2+
following release from Tg-sensitive stores. This conclusion is also
consistent with the observed rise in peak Tg-induced
[Ca2+]c in the presence of 4 or 8 µM Ec (Fig. 3), since Ca2+ that would
normally load the mitochondria remains in the cytoplasm.
Econazole and Thapsigargin Regulate BMMC Colony Forming Ability in
a Biphasic Manner--
To study the effect of ER Ca2+
depletion on mast cell viability, we incubated BMMCs with Tg and Ec and
measured their effect on clonogenicity. Preliminary studies showed that
incubation of BMMCs with as little as 30 nM Tg was
sufficient to reduce clonogenicity by 1 order of magnitude.
Surprisingly, we observed that in the presence of SLF, Ec (2 to 4 µM) completely protected mast cells from 30 nM Tg, resulting in an approximate 10-fold increase in colony forming ability (Fig.
5A; p < 0.001). This protection was lost when 8 µM Ec was used,
while 12 µM Ec reduced BMMC clonogenicity by greater than
3 orders of magnitude. When BMMCs were treated with Tg (30 nM) and maintained by IL-3 (10% WEHI-3 conditioned medium), protection from Tg toxicity was also observed from 2 to
8 µM Ec (p < 0.001). In addition,
colonies (2) were observed in the presence of 12 µM Ec
alone, but not in the presence of Tg (Fig. 5B), suggesting
that at high concentrations, this antagonism is reversed. Therefore, Ec
protected cells from Tg at concentrations where loss of
Ca2+ from the ER occurs and mitochondria are blocked from
filling with Ca2+, but these compounds synergized to
promote cell death at concentrations where Ec also blocks
Ca2+ influx. Furthermore, cell death at high Ec
concentrations was enhanced by SLF compared with IL-3.
SLF Depletes Tg-sensitive Ca2+ Stores in the
ER--
As demonstrated above, Tg becomes highly toxic to BMMCs at
concentrations which are considerably lower than those typically used
to probe ER [Ca2+]. However, at 30 nM,
Tg-induced increases in [Ca2+]c (Fig.
6A) were similar in magnitude
to Tg (2 µM; Fig. 3)-induced
[Ca2+]c, although the rate of
[Ca2+]c increase was significantly slower at the
lower concentration. Moreover, unlike in response to 2 µM
Tg, there was little decline in peak [Ca2+]c over
the time course of the measurement. Since the clonogenicity studies
demonstrated that SLF enhanced cell death in the presence of high Ec
concentrations, we measured Tg (30 nM)-induced
Ca2+ release in the presence of SLF (Fig. 6A).
This resulted in an extremely rapid increase in
[Ca2+]c which reached a magnitude higher than in
the absence of the growth factor, followed by a slow decline until
typical Tg (30 nM)-induced [Ca2+]c
was reached. To assess the ER [Ca2+] independent of
influx, these experiments were repeated in the presence of
Ni2+ which blocks all Ca2+ influx (Fig.
6B). Unlike in response to 2 µM Tg,
[Ca2+]c did not return to normal even 30 min
after challenge with the 30 nM concentration of the drug,
suggesting only partial emptying of Ca2+ in the ER. In the
presence of SLF, however, Tg (30 nM)-induced [Ca2+]c returned to basal levels in under 10 min,
supporting the interpretation that SLF enhances Tg-induced emptying of
ER Ca2+ content but does not affect cytoplasmic
Ca2+ levels.
Tg and Ec Effects on EIF2
Previous studies have reported that Tg-induced loss of protein
synthesis is reversible and that its toxicity can be attenuated by
blocking protein synthesis through other means (13, 28). To determine
whether Ec-induced EIF-2 Cycloheximide Protects from Tg Toxicity but Enhances Ec-induced
Cell Death--
To further investigate the role of protein synthesis
in mediating ER-associated toxicity, we determined the effect of
cycloheximide on both Tg and Ec-induced cell death. As shown in Fig.
9, cycloheximide partially protected
BMMCs from 30 nM Tg between 150 ng/ml and 1.5 µg/ml
irrespective of the presence of SLF (Fig. 9A) or IL-3 (Fig.
9B). However, at higher concentrations of cycloheximide, this protection was reversed. In contrast, we observed that
cycloheximide profoundly enhanced BMMC cell death induced by Ec
beginning at 500 ng/ml. Moreover, SLF-induced enhancement of this
interaction was observed at 500 ng/ml and 1.5 µg/ml. Since these
concentrations of cycloheximide are considerably lower than those
typically used in previous studies, we confirmed that protein synthesis
inhibition occurs at these concentrations. We observed a 74.2 ± 8.2% decrease in the rate of protein synthesis following a 30-min
incubation with 500 ng/ml cycloheximide in the presence of SLF and a
comparable 72.5 ± 4.9% decrease in the presence of IL-3. These
observations therefore confirm that modest suppression of protein
synthesis can partially protect cells from Tg. In contrast, Ec-induced
cell death is strongly enhanced by protein synthesis suppression.
In this study, we have investigated the relationship between ER
Ca2+ depletion, inhibition of protein synthesis, and the
induction of cell death in bone marrow-derived mast cells. We found
that mast cell Ca2+ stores consist of a Tg-sensitive ER
compartment, the Tg-insensitive SIC store and FCCP-sensitive
mitochondrial stores. We observed that low levels of Ec interfered with
Tg-stimulated mitochondrial Ca2+ loading while promoting
progressive leakage of Ca2+ from the ER. Low levels of Ec
completely reversed Tg toxicity while higher levels blocked
store-operated influx and induced cell death. Both Ec and Tg inhibited
protein synthesis, however, only SLF plus Tg or very high levels of Ec
were able to significantly stimulate EIF-2 Tg induces ER Ca2+ depletion, sustained increases in
[Ca2+]c and loading of mitochondria with
Ca2+. Several previous studies have attempted to determine
which of these events is key to Tg toxicity. Decreased ER
Ca2+ content has been shown to prevent normal protein
synthesis and trafficking, which can contribute to cell death while
sustained increases in cytosolic Ca2+ concentrations can
lead to Ca2+ overload-induced apoptosis (7, 29). In
distinguishing among these mechanisms, the current study provides some
insight. First, we observed no difference in steady-state
[Ca2+]c (~500 nM) following the
addition of either 30 nM or 2 µM Tg, despite
the fact that exposure to these two concentrations leads to a several
order of magnitude difference in BMMC clonogenicity. Second, we found
that 4 µM Ec could completely protect against 30 nM Tg-induced loss of clonogenicity, although this
concentration of Ec had no effect on steady-state Tg-induced
[Ca2+]c and in fact increased peak cytoplasmic
Ca2+ levels. These two observations both suggest that a
large increase in [Ca2+]c does not inevitably
lead to toxicity. However, Ec concentrations observed to be completely
protective for Tg were found to block loading of mitochondria with
Ca2+ with little effect on mitochondrial membrane
polarization (data not shown). In addition, under the conditions of the
current study, low concentrations of cycloheximide provided only
partial protection from the toxic effects of Tg. Taken together, these
results suggest that the ER stress associated with Ca2+
depletion plays only a partial role, while mitochondrial events play a
greater role in mediating Tg toxicity.
As shown in Figs. 7 and 8, both Tg and Ec stimulated EIF-2 The fact that both Ec and Tg were found to inhibit protein synthesis at
concentrations where EIF-2 A role for mitochondria as Ca2+ buffers has been recognized
for many years. It has been reported that mitochondria can accumulate in the immediate vicinities of the ER (5) or SOCs (31). Since it is
well established that local [Ca2+]c at the site
of Ca2+ entry far exceeds global
[Ca2+]c and mitochondria cannot fill with
Ca2+ at concentrations less than 300-500 nM,
it is likely that the cytosolic locations of mitochondria play a key
role in their ability to buffer [Ca2+]c. Given
our observation that Ec could disrupt mitochondrial Ca2+
filling without affecting mitochondrial membrane polarization, it is
possible that the imidazole disupts ER-mitochondrial junctions, perhaps
by initiating cytoplasmic remodeling systems. Alternatively, Ec may
have direct effects on mitochondrial Ca2+ loading via the
electrophoretic uniporter. Ec's unique ability to deplete ER
Ca2+ stores while preventing mitochondrial loading may
prove to be a useful tool in clarifying the role of mitochondria as
buffers of Ca2+ transients.
Several recent studies have provided evidence that Tg can activate
caspases. In particular, the ER-resident cysteine protease caspase 12 is thought to play a pivotal role as an inducer of apoptosis in
response to ER stress (12, 32). Caspase 12 can be activated by
Ca2+-regulated calpains (33) and by caspases 7 and 9 (32).
Since caspase 9 is activated upon stimulation of the mitochondrial
permeability transition, which can occur in response to mitochondrial
loading with Ca2+ (34), it is possible that the caspase
9-caspase 12 pathway is a major effector of Tg-induced apoptosis. In
this context, it is interesting to note that following treatment with
Ec that result in greater than 99.9% decreases in BMMC clonogenicity, we observed that only a relatively small percentage of cells display apoptotic phenotypes detectable by Hoechst
assays.2 These results
therefore suggest that loss of clonogenicity induced by Ec may occur
independent of full caspase activation.
In conclusion, we have found that inhibition of protein synthesis
associated with the depletion of the Tg-sensitive ER compartment can be
partially protective or toxic depending upon the extent and duration of
the Ca2+ depletion. Moreover, our observations support a
role for both ER Ca2+ depletion and mitochondrial filling
rather than cytosolic Ca2+ overload as key inducers of cell
death. Since biological agonists such as SLF can enhance the effects of
ER Ca2+-depleting agents, our results highlight the
therapeutic potential of targeting ER Ca2+ stores,
particularly in highly stimulated or activated cells.
We thank C. Cantin for assistance with the
Ca2+ measurements.
*
This work was supported by a grant from the National Cancer
Institute of Canada (to S. A. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, February 8, 2002, DOI 10.1074/jbc.M112129200
2
J. Soboloff and S. A. Berger, unpublished data.
The abbreviations used are:
[Ca2+]c, cytoplasmic Ca2+
concentration;
SLF, Steel Factor;
BMMC, bone marrow-derived mast cell;
SOC, store-operated Ca2+ channel;
ER, endoplasmic
reticulum;
Tg, thapsigargin;
Ec, econazole;
SIC, stimulus-induced
calcium store;
IL, interleukin;
BSA, bovine serum albumin;
FCCP, carbonyl cyanide p-trifluoromethoxyphenylhydrazone;
EIF-2
Sustained ER Ca2+ Depletion Suppresses Protein
Synthesis and Induces Activation-enhanced Cell Death in Mast Cells*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
phosphorylation. Cycloheximide only partially protected BMMCs
from Tg toxicity yet strongly synergized with Ec to induce cell death.
These results therefore indicate that although both Tg and Ec deplete
ER Ca2+ levels, Ec-induced cell death results from
sustained protein synthesis inhibition while Tg toxicity results
primarily from mitochondrial Ca2+ overload and secondarily
from ER stress associated with Ca2+ depletion.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(8-10). Shutdown
of protein synthesis may lead to the induction of apoptosis (11, 12).
However, a recent study by Harding et al. (13) suggested
that the inhibition of protein synthesis observed following ER stress
was protective under conditions of ER Ca2+ depletion.
Similarly, PKR-induced EIF-2
phosphorylation is well accepted as a
viral defense mechanism (14), supporting the concept that suppression
of protein synthesis can be beneficial to the cell. The precise role of
protein synthesis regulation in mediating Ca2+
depletion-associated stress and anti-viral responses therefore remains undetermined.
leading to the
production of inositol 1,4,5-trisphosphate and the mobilization of
intracellular Ca2+ (24). Using the 32D murine
myelomonocytic cell line model, we recently demonstrated that
phospholipase C-
activation was essential for the membrane-bound
form of SLF to support c-Kit-positive 32D cells in vitro and
in vivo (22). Moreover, we have shown that inhibition of
store-operated Ca2+ channels (SOCs) using Ec, ketotifen, or
Ni2+, while concurrently stimulating cells with SLF,
results in the induction of activation enhanced cell death (21) in both
BMMCs and 32D-Kit leukemia cells. In the current study, we have
established the physiological identities of BMMC Ca2+
stores and characterized Ec-induced changes in ER Ca2+
content and mitochondrial loading. We further show that in BMMCs depleted of ER Ca2+, suppression of protein synthesis can
be either partially protective or profoundly lethal, depending upon the
extent and the duration of suppression.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-mercaptoethanol and antibiotics (Sigma).
Where R is the ratio of the fluorescence intensities
measured at 405 and 450 nm during the experiments and F is
the fluorescence intensity measured at 450 nm.
Rmin, Rmax,
Fmin, and Fmax were determined from in situ calibration of unlysed cells using 4 µM ionomycin in the absence (Rmin
and Fmin; 10 mM EGTA) and presence (Rmax and Fmax) of
Ca2+. Kd (250 nM) is the
dissociation constant for indo-1 at 37 °C.
Rmin, Rmax,
Fmin, and Fmax varied
depending upon settings and were determined at the beginning of each
experimental procedure.
(Eq. 1)
Phosphorylation--
Assays for EIF-2
phosphorylation were performed in BMMC cells in the presence of SLF
(500 ng/ml) or IL-3 (10% WEHI). Cells were treated with Ec (0, 4, 8, and 12 µM) in the absence or presence of Tg (30 nM) for 30 min or 6 h. After centrifugation (1250 rpm), the cells were lysed in chilled RIPA buffer (Nonidet P-40 (1% v/v), sodium deoxycholate (0.05% w/v), SDS (0.1% w/v)) containing phenylmethylsulfonyl fluoride (10 µg/ml), and protease inhibitor mixture I (Sigma)) by sonication (30 s) followed by an incubation period (30 min; 4 °C). The supernatants (18,000 × g; 20 min; 4 °C) were stored in aliquots (
20 °C) for
subsequent analysis. Proteins were resolved by 15% SDS-PAGE and then
electroblotted to nitrocellulose membranes. After transfer, the gels
were stained with Coomassie Blue to verify even sample loading.
(phosphoserine 51 specific; BIOSOURCE
International) in 2% blocking solution (1:1000). Membranes were then
washed (2 × 7 min) in TBST and incubated with secondary antibody
(30 min; goat anti-rabbit IgG conjugated to horseradish peroxidase;
1:2500 in 2% blocking solution). Membranes were then washed in TBST
(3 × 5 min) followed by Tris-buffered saline (TBS; 1 × 5 min; Tris (10 mM), NaCl (150 mM), pH 8.0).
Peroxidase activity was visualized using the ECL kit as per the
manufacturer's instructions.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (12K):
[in a new window]
Fig. 1.
Physiologically and pharmacologically
distinct intracellular Ca2+ stores in BMMCs. A,
BMMCs were treated with ryanodine (1 µM). B,
BMMCs pretreated with Ni2+ were exposed to FCCP (1 µM), Tg (2 µM), and then ionomycin (4 µM)/EGTA (3 mM) to reveal the presence of the
SIC store. As a control (Ctl), cells were treated with
ionomycin (4 µM)/EGTA (3 mM) alone, to
compare the amount of Ca2+ released from the SIC store with
total intracellular Ca2+ content. Data are representative
of three separate experiments.

View larger version (12K):
[in a new window]
Fig. 2.
Econazole-induced mobilization of
Ca2+ empties Tg-sensitive intracellular Ca2+
stores. A, BMMC were exposed to econazole (30 µM) without pretreatment, followed by Tg (2 µM). B, BMMCs were exposed to FCCP (1 µM), Ec (30 µM), Tg (2 µM),
and then ionomycin (4 µM)/EGTA (3 mM) to
demonstrate the effect of Ec on the SIC store. Data are representative
of three separate experiments.

View larger version (25K):
[in a new window]
Fig. 3.
The effect of econazole on
thapsigargin-sensitive Ca2+ stores. Cells were
incubated in the presence of econazole (0, 4, 8, 12 or 15 µM) and either SLF (500 ng/ml; panels A,
C, and D) or IL-3 (10 ng/ml; panels B,
E, and F) for 3 h at 37 °C. BMMCs were
exposed to thapsigargin (Tg; 2 µM) in the absence
(panels A-C) or presence of Ni2+ (5 mM; panels D-F). Panels A, B,
D, and E depict representative experiments, while
panels C and F show the average change in peak
Tg-induced [Ca2+]c (n = 3).

View larger version (11K):
[in a new window]
Fig. 4.
The effect of econazole on
thapsigargin-induced loading of mitochondrial Ca2+
stores. Cells were preincubated with Ec (0, 4, and 15 µM) for 3 h at 37 °C. One hour immediately prior
to the beginning of the experiment, thapsigargin (2 µM)
was added to induce Ca2+ overload. As depicted in the
figure, BMMCs were exposed to FCCP (1 µM) while
monitoring their response by flow cytometry. The data is representative
of three separate experiments.

View larger version (18K):
[in a new window]
Fig. 5.
Ec-thapsigargin interactions decrease BMMC
colony forming ability in a biphasic manner. BMMCs (5 × 105 cells/ml) were incubated in the presence or absence of
econazole (0, 4, 8, or 12 µM) and/or thapsigargin (30 nM) in the presence of either SLF (1 µg/ml; panel
A) or IL-3 (10% WEHI; panel B). After a 24-h
incubation period, 104 cells were transferred into
methylcellulose (0.9%) containing IL-3 (10% WEHI), SLF (1 µg/ml),
and IL-4 (1.5 ng/ml) incubated for 7 to 9 days. Data are expressed as
the number of colony forming units per plate
(CFU/104 cells). Significant
differences from the untreated samples are indicated within the graphs
with: *, p < 0.05; **, p < 0.01; or
***, p < 0.001.

View larger version (19K):
[in a new window]
Fig. 6.
SLF enhances thapsigargin-induced
mobilization of Ca2+. A, exposure of BMMCs
to thapsigargin (Tg; 30 nM) results in slow leakage of
Ca2+ into the cytosol which is enhanced by the addition of
SLF (1 µg/ml). B, in the presence of Ni2+ (3 mM), Tg (30 nM) induced Ca2+
release is sustained in the absence of SLF (1 µg/ml) only.
Phosphorylation and Protein
Synthesis--
Tg has previously been shown to stimulate EIF-2
phosphorylation resulting in decreases in the rate of protein
synthesis. Although some controversy exists regarding the identity of
the protein kinase which initiates the unfolded protein response (PERK versus PKR), the target protein for both molecules is
EIF-2
. We therefore measured the effect of Tg and Ec on EIF-2
phosphorylation and protein synthesis. As shown in Fig.
7 (panels A and B),
30 nM Tg plus SLF stimulated EIF-2
phosphorylation in
BMMCs, correlating with the ER depleting effects of this combination
(Fig. 6B). In the presence of SLF, Ec alone also stimulated
EIF2
phosphorylation, however, only at the highest concentration
tested. In contrast, in the presence of IL-3, 30 nM Tg was
insufficient to stimulate significant levels of EIF2
phosphorylation. In fact, in the presence of IL-3, significant EIF2
phosphorylation was only observed following treatment with both 30 nM Tg plus 12 µM Ec. When protein synthesis rates were measured, we observed that both Tg and Ec were able to
suppress protein synthesis both alone and in combination (Fig. 7C). However, additive effects of the two compounds were
only observed at the higher Ec concentrations.

View larger version (37K):
[in a new window]
Fig. 7.
Econazole and thapsigargin synergistically
block protein synthesis via EIF-2
phosphorylation. A,
BMMCs were incubated in the presence or absence of Ec (4, 8, and 12 µM) ± Tg (30 nM) for 30 min in the
presence of SLF (500 ng/ml; left) or IL-3 (10% WEHI-cm;
right). To detect the phosphorylation of EIF-2
(upper blots), treated cells (106/lane) were
lysed, separated by SDS-PAGE, electroblotted to nitrocellulose, and
hybridized to an antibody specific to EIF-2
phosphorylated at serine
51 (BIOSOURCE). To determine protein loading,
hybridized antibody was removed by acid hydrolysis and the membranes
were reprobed with an antibody specific to actin (middle
blots). B, EIF-2
phosphorylation and actin levels
were measured by densitometry and normalized to control. Reported data
is an average of three independent experiments. C, to
measure the rate of protein synthesis, treated cells (7.5 × 105/sample) were incubated with [3H]leucine
for the final 10 min of incubation. Proteins were separated using
trichloroacetic acid precipitation and counts were determined in a
liquid scintillation counter. The data are representative of three
separate experiments.
phosphorylation and protein synthesis
inhibition is similarly reversible, EIF-2
phosphorylation and
protein synthesis rates were evaluated following a 6-h incubation. As
shown in Fig. 8 (panels A and
B), both Ec- and Tg-induced EIF2
phosphorylation levels were reduced
in all treated cells compared with the 30-min end point. When protein
synthesis was measured, we observed that all treated cells showed some
degree of recovery, however, significant suppression of protein
synthesis was maintained for all cells exposed to toxic levels of Ec
alone or Ec plus Tg. These results therefore indicate that sustained
suppression of protein synthesis correlates with Ec-mediated toxicity.
However, the ability of Ec to protect Tg-treated cells does not
correlate with either enhancement or suppression of protein
synthesis.

View larger version (38K):
[in a new window]
Fig. 8.
Partial recovery of EIF-2
phosphorylation and protein synthesis following 6 h
incubation with econazole and thapsigargin. BMMCs were incubated
in the presence or absence of Ec (4, 8, and 12 µM) ± Tg (30 nM) for 6 h in the presence of SLF (500 ng/ml; left) or IL-3 (10% WEHI-cm; right). To
detect the phosphorylation of EIF-2
(upper blots),
treated cells (106/lane) were lysed, separated by SDS-PAGE,
electroblotted to nitrocellulose, and hybridized to an antibody
specific to EIF-2
phosphorylated at serine 51 (BIOSOURCE). To determine protein loading,
hybridized antibody was removed by acid hydrolysis and the membranes
were reprobed with an antibody specific to actin (middle
blots). B, EIF-2
phosphorylation and actin levels
were measured by densitometry and normalized to control. Reported data
is an average of three independent experiments. C, to
measure the rate of protein synthesis, treated cells (7.5 × 105/sample) were incubated with [3H]leucine
for the final 10 min of incubation. Proteins were separated using
trichloroacetic acid precipitation and counts were determined in a
liquid scintillation counter. The data are representative of three
separate experiments.

View larger version (21K):
[in a new window]
Fig. 9.
Cycloheximide enhances econazole-induced loss
of clonogenicity but protects from Tg-induced loss of
clonogenicity. BMMCs (5 × 105 cells/ml) were
incubated in the presence or absence of cycloheximide (0.05, 0.15, 0.5, 1.5, 5, or 15 µg/ml) ± thapsigargin (30 nM) or
econazole (12 µM) in the presence of either SLF (1 µg/ml; panel A) or IL-3 (10% WEHI; panel B).
After a 24-h incubation period, 104 cells were transferred
into methylcellulose (0.9%) containing IL-3 (10% WEHI), SLF (1 µg/ml), and IL-4 (1.5 ng/ml) incubated for 7 to 9 days. Data are
expressed as the number of colony forming units per plate
(CFU/104 cells).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
phosphorylation. In
addition, we observed that cycloheximide provided only partial
protection against Tg toxicity yet profoundly synergized with Ec to
induce cell death. These results therefore indicate that although both
Tg and Ec deplete ER Ca2+ levels, their mechanism of
toxicity in BMMCs is different. Tg's mechanism of toxicity involves
primarily mitochondrial loading with Ca2+ and secondarily
from ER stress associated with Ca2+ depletion while Ec
induces mast cell death through profound, sustained suppression of
protein synthesis.
phosphorylation and suppressed protein synthesis. However, the relationship between these end points, Ca2+ depletion, and
mast cell viability is complex. Conditions resulting in enhanced
Ca2+ depletion from the ER in general led to increased
EIF-2
phosphorylation and enhanced suppression of protein synthesis.
However, by 6 h, EIF-2
phosphorylation was lost, even in
conditions where significant suppression of protein synthesis was
maintained. Furthermore, by the 6-h time point, significant Ec-induced
suppression of protein synthesis was only observed at concentrations
where it is lethal to mast cells. These observations provide additional
support for the interpretation that Ec does not protect Tg-exposed
BMMCs through protein synthesis suppression. However, sustained
inhibition of protein synthesis does correlate with loss of
clonogenicity. The fact that cycloheximide strongly synergized with Ec
to promote mast cell death further suggests that profound, sustained
protein synthesis inhibition is the major mechanism by which Ec kills mast cells. Protein synthesis inhibition was also identified as a
likely cause of growth arrest observed with the related compound clotrimazole (28).
phosphorylation was not observed may
indicate that small, undetectable changes in EIF-2
phosphorylation
are sufficient to effect substantial changes in the rate of protein
synthesis. Alternatively, ER Ca2+ depletion caused by these
compounds may simply block protein synthesis through other pathways (8,
30) or in a nonspecific manner. Future studies may help to clarify the
mechanism by which Ec and Tg inhibit protein synthesis. Nevertheless,
our observations indicate that ER depletion through the combination of
Ca2+ influx blockade with mobilizing agents and biological
agonists such as SLF, represents a potent approach for inducing
ER-based cell death.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
To whom all correspondence and reprint requests should be
addressed: Arthritis and Immune Disorder Research Center, University Health Network, 620 University, Suite 700, Toronto, Ontario M5G 2M9,
Canada. Tel.: 416-946-6541; Fax: 416-946-6589; E-mail:
Berger@uhnres.utoronto.ca.
![]()
ABBREVIATIONS
, eukaroytic initiation factor 2
.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Fewtrell, C.
(1993)
Annu. Rev. Physiol.
55,
427-454[CrossRef][Medline]
[Order article via Infotrieve] 2.
Putney, J. W., Jr.,
and McKay, R. R.
(1999)
Bioessays
21,
38-46[CrossRef][Medline]
[Order article via Infotrieve] 3.
Boitier, E.,
Rea, R.,
and Duchen, M. R.
(1999)
J. Cell Biol.
145,
795-808 4.
Herrington, J.,
Park, Y. B.,
Babcock, D. F.,
and Hille, B.
(1996)
Neuron
16,
219-228[CrossRef][Medline]
[Order article via Infotrieve] 5.
Golovina, V. A.,
and Blaustein, M. P.
(1997)
Science
275,
1643-1648 6.
Pizzo, P.,
Fasolato, C.,
and Pozzan, T.
(1997)
J. Cell Biol.
136,
355-366 7.
Kass, G. E. N.,
and Orrenius, S.
(1999)
Environmen. Health Perspect.
107,
25-35
8.
Kaufman, R. J.
(1999)
Genes Dev.
13,
1211-1233 9.
Corbett, E. F.,
and Michalak, M.
(2000)
Trends Biochem. Sci.
25,
307-311[CrossRef][Medline]
[Order article via Infotrieve] 10.
Meldolesi, J.,
and Pozzan, T.
(1998)
Trends Biochem. Sci
23,
10-14[CrossRef][Medline]
[Order article via Infotrieve] 11.
Bian, X.,
Hughes, F. M., Jr.,
Huang, Y.,
Cidlowski, J. A.,
and Putney, J. W., Jr.
(1997)
Am. J. Physiol.
272,
C1241-1249 12.
Nakagawa, T.,
Zhu, H.,
Morishima, N., Li, E., Xu, J.,
Yankner, B. A.,
and Yuan, J.
(2000)
Nature
403,
98-103[CrossRef][Medline]
[Order article via Infotrieve] 13.
Harding, H. P.,
Zhang, Y.,
Bertolotti, A.,
Zeng, H.,
and Ron, D.
(2000)
Mol. Cell
5,
897-904[CrossRef][Medline]
[Order article via Infotrieve] 14.
Williams, B. R.
(1999)
Oncogene
18,
6112-6120[CrossRef][Medline]
[Order article via Infotrieve] 15.
Jan, C. R., Ho, C. M., Wu, S. N.,
and Tseng, C. J.
(1999)
Biochim. Biophys. Acta
1448,
533-542[Medline]
[Order article via Infotrieve] 16.
Franzius, D.,
Hoth, M.,
and Penner, R.
(1994)
Pflugers Arch.
428,
433-438[CrossRef][Medline]
[Order article via Infotrieve] 17.
Lawson, D.,
Fewtrell, C.,
and Raff, M. C.
(1978)
J. Cell Biol.
79,
394-400 18.
Kanner, B. I.,
and Metzger, H.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
5744-5748 19.
Wodnar-Filipowicz, A.,
and Moroni, C.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
777-781 20.
Baumgartner, R. A.,
Yamada, K.,
Deramo, V. A.,
and Beaven, M. A.
(1994)
J. Immunol.
153,
2609-2617[Abstract] 21.
Gommerman, J. L.,
and Berger, S. A.
(1998)
Blood
91,
1891-1900 22.
Gommerman, J. L.,
Sittaro, D.,
Klebasz, N. Z.,
Williams, D. A.,
and Berger, S. A.
(2000)
Blood
96,
3734-3742 23.
Broudy, V. C.
(1997)
Blood
90,
1345-1364 24.
Columbo, M.,
Botana, L. M.,
Horowitz, E. M.,
Lichtenstein, L. M.,
and MacGlashan, D. J.
(1994)
Biochem. Pharmacol.
47,
2137[CrossRef][Medline]
[Order article via Infotrieve] 25.
Berger, S. A.,
Mak, T. W.,
and Paige, C. J.
(1994)
J. Exp. Med.
180,
471 26.
Grynkiewcz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450 27.
Gamberucci, A.,
Fulceri, R.,
Benedetti, A.,
and Bygrave, F. L.
(1998)
Biochem. Biophys. Res. Commun.
248,
75-77[CrossRef][Medline]
[Order article via Infotrieve] 28.
Aktas, H.,
Fluckiger, R.,
Acosta, J. A.,
Savage, J. M.,
Palakurthi, S. S.,
and Halperin, J. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8280-8285 29.
Orrenius, S.,
Burkitt, M. J.,
Kass, G. E. N.,
Dypbukt, J. M.,
and Nicotera, P.
(1992)
Ann. Neurol.
32,
S33-S42 30.
Iwawaki, T.,
Hosoda, A.,
Okuda, T.,
Kamigori, Y.,
Nomura-Furuwatari, C.,
Kimata, Y.,
Tsuru, A.,
and Kohno, K.
(2001)
Nat. Cell Biol.
3,
158-164[CrossRef][Medline]
[Order article via Infotrieve] 31.
Hoth, M.,
Fanger, C. M.,
and Lewis, R. S.
(1997)
J. Cell Biol.
137,
633-648 32.
Rao, R. V.,
Hermel, E.,
Castro-Obregon, S.,
del Rio, G.,
Ellerby, L. M.,
Ellerby, H. M.,
and Bredesen, D. E.
(2001)
J. Biol. Chem.
276,
33869-33874 33.
Nakagawa, T.,
and Yuan, J.
(2000)
J. Cell Biol.
150,
887-894 34.
Gunter, T. E.,
Buntinas, L.,
Sparagna, G.,
Eliseev, R.,
and Gunter, K.
(2000)
Cell Calcium
28,
285-296[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Inoue, Y. Suzuki, T. Yoshimaru, and C. Ra Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway J. Leukoc. Biol., May 1, 2008; 83(5): 1218 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yu, M. Niapour, Y. Zhang, and S. A. Berger Mitochondrial regulation by c-Myc and hypoxia-inducible factor-1{alpha} controls sensitivity to econazole Mol. Cancer Ther., March 1, 2008; 7(3): 483 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Morales, A. Diez, A. Puyet, P. J. Camello, C. Camello-Almaraz, J. M. Bautista, and M. J. Pozo Calcium controls smooth muscle TRPC gene transcription via the CaMK/calcineurin-dependent pathways Am J Physiol Cell Physiol, January 1, 2007; 292(1): C553 - C563. [Abstract] [Full Text] [PDF] |
||||
![]() |
Sic. L. Chan, D. Liu, G. A. Kyriazis, P. Bagsiyao, X. Ouyang, and M. P. Mattson Mitochondrial Uncoupling Protein-4 Regulates Calcium Homeostasis and Sensitivity to Store Depletion-induced Apoptosis in Neural Cells J. Biol. Chem., December 8, 2006; 281(49): 37391 - 37403. [Abstract] [Full Text] [PDF] |
||||